Furotil Plus® 125 mg Tablet: Contains Cefuroxime Axetil (equivalent to Cefuroxime 125 mg) and Potassium Clavulanate (equivalent to Clavulanic Acid 31.25 mg).
Furotil Plus® 250 mg Tablet: Contains Cefuroxime Axetil (equivalent to Cefuroxime 250 mg) and Potassium Clavulanate (equivalent to Clavulanic Acid 62.5 mg).
Furotil Plus® 500 mg Tablet: Contains Cefuroxime Axetil (equivalent to Cefuroxime 500 mg) and Potassium Clavulanate (equivalent to Clavulanic Acid 125 mg).
Furotil Plus® Powder for Suspension: Each 5 mL reconstituted suspension contains Cefuroxime Axetil (equivalent to Cefuroxime 125 mg) and Potassium Clavulanate (equivalent to Clavulanic Acid 31.25 mg).

Cefuroxime Axetil is a second-generation cephalosporin antibiotic that kills bacteria by inhibiting cell wall synthesis. Clavulanic Acid is a beta-lactamase inhibitor that protects cefuroxime from bacterial resistance mechanisms by inactivating beta-lactamase enzymes.

Pharyngitis/Tonsillitis

Acute Bacterial Otitis Media

Acute Bacterial Maxillary Sinusitis

Chronic Bronchitis Exacerbations

Uncomplicated Skin and Skin-Structure Infections

Urinary Tract Infections

Uncomplicated Gonorrhea

Early Lyme Disease

Impetigo

Route: Oral

Tablets: Can be taken with or without food.

Suspension: Recommended to be taken with food.

For Adults & Pediatric Patients (13 years and older)

Pharyngitis/Tonsillitis (mild to moderate): 250 mg every 12 hours for 10 days.

Acute Sinusitis (mild to moderate): 250 mg every 12 hours for 10 days.

Chronic Bronchitis Exacerbation (mild to moderate): 250 or 500 mg every 12 hours for 10 days.

Uncomplicated Skin Infections: 250 or 500 mg every 12 hours for 10 days.

Urinary Tract Infections: 250 mg every 12 hours for 7 to 10 days.

Gonorrhea: 1,000 mg single dose.

Early Lyme Disease: 500 mg every 12 hours for 20 days.

For Pediatric Patients (3 months to 12 years) - Oral Suspension

Pharyngitis/Tonsillitis: 20 mg/kg every 12 hours for 10 days.

Acute Otitis Media/Sinusitis/Impetigo: 30 mg/kg every 12 hours for 10 days (Maximum dose 1,000 mg).

Hypersensitivity Reactions: Discontinue use immediately if severe reactions occur.

Clostridium difficile-associated Diarrhea (CDAD): Monitor for diarrhea and evaluate for CDAD if necessary.

Common Side Effects

Diarrhea, nausea/vomiting, and taste disturbances.

Rare: Headache, dizziness, transient increases in liver enzymes.

Use cautiously in pregnancy, especially during the first trimester.

Cefuroxime is excreted in breast milk, so consider discontinuing breastfeeding during treatment.

May cause convulsions or encephalopathy. Dialysis can reduce cefuroxime levels.

Tablets: Store in a dry place at temperatures not exceeding 25°C. Protect from light and moisture.

Suspension: Store reconstituted suspension in a refrigerator (2-8°C) and use within 7 days. Unreconstituted powder should be stored in a dry place at temperatures not exceeding 25°C.